Day One Biopharmaceuticals, Inc. Common Stock (DAWN) Stock Price, Quote & AI Analysis
Live DAWN stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Day One Biopharmaceuticals, Inc. Common Stock.
TradeVae provides AI-driven analysis and real-time market intelligence for Day One Biopharmaceuticals, Inc. Common Stock (DAWN), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Day One Biopharmaceuticals, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Day One Biopharmaceuticals, Inc. Common Stock Overview
Company information
Company Overview
Day One Biopharmaceuticals, Inc. operates as a holding company. The firm, through its subsidiary, develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel C. Blackman in November 2018 and is headquartered in Brisbane, CA.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Day One Biopharmaceuticals, Inc. Common Stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...